Sansum Diabetes Research Institute (SDRI) is actively recruiting children and adolescent participants for pediatric clinical trials.

With a commitment to advancing diabetes care, SDRI invites children, ages 2 to 18, with type 1 diabetes and their families to join its efforts in helping to advance new treatments and technologies.
SDRI conducts an average of 25 clinical trials annually, engaging 700-1,000 participants each year.
Among SDRI’s industry partners are: Abbott, Dexcom, Insulet, Eli Lilly, MannKind, Medtronic Diabetes, Novo Nordisk, Sanofi, Tandem Diabetes Care.
“We are proud to share that SDRI’s partnership with industry sponsors furthers critical treatment options that improves the quality and longevity of life for those living with diabetes,” SDRI said.
“We are dedicated to reducing the burden of diabetes for all people, especially children,” said Dr. Kristin Castorino, SDRI vice president of clinical research and senior investigator.
“Our pediatric research programs offer families the opportunity to be part of the latest advancements in diabetes science, contributing to innovations that will shape the future of diabetes care and hopefully reduce the burden, so kids can think about being an astronaut or race car driver and not let diabetes get in the way of their dreams.” Dr. Castorino said.
“I was devastated when my two-year-old son Blake was diagnosed with type 1 diabetes,” said Ashley, mother of Blake, now 11 years old. “That day changed everything for our family because we had to grieve the life we once imagined for Blake.
“When Blake had the opportunity to participate in a clinical trial for an artificial pancreas system at SDRI, I was given hope for his future,” she said. “His blood glucose levels were more stable than ever before, which meant for the for the first time since his diagnosis of diabetes, our family was able to sleep through the night.
“We were no longer waking up multiple times throughout the night to ensure his glucose levels were in a safe range.
“I am so grateful Blake was asked to participate in this clinical trial, and I am so hopeful for future breakthroughs that will improve the management of his diabetes.”
By participating in SDRI’s pediatric clinical trials, families not only contribute to vital research but also gain access to cutting-edge treatments and technologies under the expert care of SDRI’s team.
SDRI is committed to providing a supportive and compassionate environment for all participants, including Spanish translation services opening up active participation for more people in our community.
For more on how to participate in SDRI’s pediatric clinical trials, contact Christian Farfan at cfarfan@sansum.org or visit sansum.org.

